Intranasal Ketamine for Late-Life Depression and Suicidal Ideation

Summary

The investigators of this study plan to investigate the feasibility and efficacy of repeated doses of intranasal ketamine in severely depressed patients who are at least 65 years of age and experiencing suicidal ideation. The results of the study could lead to development of new strategies for treating depression.

Timeline

Start

2015-07

Primary completion

2015-07

Completion

2015-07

Outcome

Outcome not reported

Stopped (Business): “No funding”

Drugs

Indications